A critical analysis of natural agents studied in vitro or in vivo for targeting PD-1/PD-L1 reveals that numerous natural compounds demonstrated efficacy against cancer across various studies, with many either having undergone clinical evaluation or currently being evaluated. Here, CD274 is linked to cancer.